학술논문
Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD
Document Type
Article
Author
Source
In Pulmonary Pharmacology & Therapeutics October 2017 46:69-77
Subject
Language
ISSN
1094-5539